发明名称 PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-MIRNA ANTISENSE OLIGONUCLEOTIDES
摘要 <p>The invention provides oligonucleotides 8 - 22 nucleotides in length, for inhibition of a microRNA target in a cell, which comprise a high proportion of high affinity nucleotide analogue units as well as LNA units. The oligonucleotides are particularly effective at alleviating miRNA repression in vivo. It is found that the incorporation of high affinity nucleotide analogues into the oligonucleotides results in highly effective anti-microRNA molecules which appear to function via the formation of almost irreversible duplexes with the miRNA target, rather than RNA cleavage based mechanisms, such as mechanisms associated with RNaseH or RISC.</p>
申请公布号 EP2007889(A2) 申请公布日期 2008.12.31
申请号 EP20070722549 申请日期 2007.03.30
申请人 SANTARIS PHARMA A/S 发明人 ELMEN, JOACIM;KEARNEY, PHIL;KAUPPINEN, SAKARI
分类号 A61K31/713;A61P35/00;C07H21/02;C12N15/113 主分类号 A61K31/713
代理机构 代理人
主权项
地址